ArticleNPJ breast cancer2022

Associations with response to Poly(ADP-ribose) Polymerase (PARP) inhibitors in patients with metastatic breast cancer.

A Desnoyers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.